Yoshitomi Kanemitsu

1.1k total citations
12 papers, 523 citations indexed

About

Yoshitomi Kanemitsu is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yoshitomi Kanemitsu has authored 12 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yoshitomi Kanemitsu's work include Metabolism and Genetic Disorders (2 papers), Diet and metabolism studies (2 papers) and Dialysis and Renal Disease Management (2 papers). Yoshitomi Kanemitsu is often cited by papers focused on Metabolism and Genetic Disorders (2 papers), Diet and metabolism studies (2 papers) and Dialysis and Renal Disease Management (2 papers). Yoshitomi Kanemitsu collaborates with scholars based in Japan, New Zealand and United States. Yoshitomi Kanemitsu's co-authors include Yoshihisa Tomioka, Hiroki Tsukamoto, Yotaro Matsumoto, Takaaki Abe, Eikan Mishima, Sadayoshi Ito, Takehiro Suzuki, Kôichi Kikuchi, Chitose Suzuki and Noriko Fukuda and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Kidney International.

In The Last Decade

Yoshitomi Kanemitsu

12 papers receiving 518 citations

Peers

Countries citing papers authored by Yoshitomi Kanemitsu

Since Specialization

Citations

This map shows the geographic impact of Yoshitomi Kanemitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitomi Kanemitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitomi Kanemitsu more than expected).

Fields of papers citing papers by Yoshitomi Kanemitsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitomi Kanemitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitomi Kanemitsu. The network helps show where Yoshitomi Kanemitsu may publish in the future.

Co-authorship network of co-authors of Yoshitomi Kanemitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitomi Kanemitsu. A scholar is included among the top collaborators of Yoshitomi Kanemitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitomi Kanemitsu. Yoshitomi Kanemitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial 2024 ·EClinicalMedicine ·Tomohiko Ishihara, Masayoshi Tada, Yoshitomi Kanemitsu, Yuji Takahashi, Kinya Ishikawa, (unknown), Makito Hirano, Takanori Yokota, Eiko N. Minakawa, Koichi Saito, Yoshitaka Nagai, Osamu Onodera	2
2	Methylmercury directly modifies the 105th cysteine residue in oncostatin M to promote binding to tumor necrosis factor receptor 3 and inhibit cell growth 2023 ·Archives of Toxicology ·Takashi Toyama, (unknown), Yoshitomi Kanemitsu, Takashi Hasegawa, Takuya Noguchi, Jin Yong Lee, Atsushi Matsuzawa, Akira Naganuma, Gi‐Wook Hwang	3
3	Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS/MS 2019 ·Scientific Reports ·Yoshitomi Kanemitsu, Eikan Mishima, Masamitsu Maekawa, Yotaro Matsumoto, Daisuke Saigusa, Hiroaki Yamaguchi, Jiro Ogura, Hiroki Tsukamoto, Yoshihisa Tomioka, Takaaki Abe, Nariyasu Mano	21
4	Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1–IKKϵ–IRF3 axis activation 2018 ·Journal of Biological Chemistry ·Hiroki Tsukamoto, (unknown), (unknown), Yohei Kobayashi, (unknown), (unknown), (unknown), (unknown), Muneo Numasaki, Yoshitomi Kanemitsu, Yotaro Matsumoto, Tomonori Nochi, (unknown), Hisashi Aso, Yoshihisa Tomioka	145
5	The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice 2018 ·Neuroscience ·Hisanao Izumi, Yasuharu Shinoda, Takashi Saito, Takaomi C. Saido, Keita Sato, Yasushi Yabuki, Yotaro Matsumoto, Yoshitomi Kanemitsu, Yoshihisa Tomioka, Nona Abolhassani, Yusaku Nakabeppu, Kohji Fukunaga	21
6	Generation and Characterization of Anti-phenyl Sulfate Monoclonal Antibodies and a Potential Use for Phenyl Sulfate Analysis in Human Blood 2018 ·Biological and Pharmaceutical Bulletin ·Yoshitomi Kanemitsu, Hiroki Tsukamoto, Yotaro Matsumoto, Kanako Nozawa‐Kumada, Yoshinori Kondo, Takaaki Abe, Yoshihisa Tomioka	3
7	Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS–based metabolomics approach 2017 ·Kidney International ·Eikan Mishima, Shinji Fukuda, (unknown), Akinori Yuri, Yoshitomi Kanemitsu, Yotaro Matsumoto, Yasutoshi Akiyama, Noriko Fukuda, Hiroki Tsukamoto, (unknown), Hisato Shima, Kôichi Kikuchi, Chitose Suzuki, Takehiro Suzuki, Yoshihisa Tomioka, Tomoyoshi Soga, Sadayoshi Ito, Takaaki Abe	184
8	Simultaneous quantitative analysis of uremic toxins by LC–MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column 2017 ·Journal of Chromatography B ·Yoshitomi Kanemitsu, (unknown), Yotaro Matsumoto, Hiroki Tsukamoto, Daisuke Saigusa, (unknown), (unknown), Takaaki Abe, Yoshihisa Tomioka	31
9	Rapid and selective simultaneous quantitative analysis of modified nucleosides using multi-column liquid chromatography-tandem mass spectrometry 2017 ·Journal of Analytical Science & Technology ·(unknown), Yoshitomi Kanemitsu, (unknown), (unknown), Hiroki Tsukamoto, Yotaro Matsumoto, Takaaki Abe, Yoshihisa Tomioka	3
10	Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model 2017 ·American Journal of Physiology-Renal Physiology ·Eikan Mishima, Shinji Fukuda, Yoshitomi Kanemitsu, Daisuke Saigusa, (unknown), (unknown), Yotaro Matsumoto, Hiroki Tsukamoto, (unknown), Tomoya Tsukimi, Noriko Fukuda, Hsin‐Jung Ho, Kôichi Kikuchi, Chitose Suzuki, (unknown), Takehiro Suzuki, Sadayoshi Ito, Tomoyoshi Soga, Yoshihisa Tomioka, Takaaki Abe	87
11	[A CASE OF ANAPHYLAXIS IN THE PEDIATRIC PATIENT WITH MILK ALLERGY DUE TO TRACES OF MILK PROTEIN IN THE LACTOSE USED AS AN EXCIPIENT OF INAVIR INHALATION]. 2016 ·PubMed ·Miki Morikawa, Yoshitomi Kanemitsu, Hiroki Tsukamoto, (unknown), (unknown)	11
12	Determination of Asymmetric Dimethylarginine and Symmetric Dimethylarginine in Biological Samples of Mice Using LC/MS/MS 2011 ·American Journal of Analytical Chemistry ·Daisuke Saigusa, Mai Takahashi, Yoshitomi Kanemitsu, Ayako Ishida, Takaaki Abe, Tohru Yamakuni, Naoto Suzuki, Yoshihisa Tomioka	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact